Hyperion DeFi (B0U) Stock Overview
An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
B0U Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Hyperion DeFi, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.88 |
| 52 Week High | US$12.10 |
| 52 Week Low | US$2.38 |
| Beta | 2.81 |
| 1 Month Change | -11.66% |
| 3 Month Change | -70.16% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -73.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| B0U | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -11.1% | 2.6% | 1.0% |
| 1Y | n/a | 12.5% | 15.0% |
Return vs Industry: Insufficient data to determine how B0U performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how B0U performed against the German Market.
Price Volatility
| B0U volatility | |
|---|---|
| B0U Average Weekly Movement | 19.1% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: B0U's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine B0U's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 14 | Hyunsu Jung | hyperiondefi.com |
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; Senju Pharmaceutical Co., Ltd.
Hyperion DeFi, Inc. Fundamentals Summary
| B0U fundamental statistics | |
|---|---|
| Market cap | €24.83m |
| Earnings (TTM) | -€22.53m |
| Revenue (TTM) | €294.73k |
Is B0U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B0U income statement (TTM) | |
|---|---|
| Revenue | US$345.32k |
| Cost of Revenue | US$3.10m |
| Gross Profit | -US$2.76m |
| Other Expenses | US$23.64m |
| Earnings | -US$26.40m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.23 |
| Gross Margin | -798.12% |
| Net Profit Margin | -7,643.89% |
| Debt/Equity Ratio | 10.8% |
How did B0U perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/02 20:17 |
| End of Day Share Price | 2026/01/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hyperion DeFi, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James McIlree | Chardan Capital Markets, LLC |
| Timothy Chiang | Northland Capital Markets |
| Esther Rajavelu | Oppenheimer & Co. Inc. |